Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.33 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3466752 | 0.63 | HSD17B10 (0.44) | HSD17B10ALDH1A1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL3468019 | 0.63 | HSD17B10 (0.50) | HSD17B10ALDH1A1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1286933 | 0.60 | MEN1 (0.40) | HSD17B10ALDH1A1KMT2A | |
| SCHEMBL9373154 | 0.55 | SRC (0.41) | HSD17B10ALDH1A1CYP2C19MAPTTSHR | |
| SCHEMBL13105905 | 0.51 | MAPT (0.30) | HSD17B10MAPTTSHRKMT2A | |
| Bicarbonate SCHEMBL551758 | 0.47 | — | — | |
| Bicarbonate SCHEMBL551756 | 0.47 | CA1 (0.83) | ALDH1A1TSHR | |
| SCHEMBL482882 | 0.46 | — | — | |
| SCHEMBL445370 | 0.46 | ALDH1A1 (0.46) | HSD17B10ALDH1A1CYP2C19MAPTTSHR | |
| SCHEMBL168369 | 0.46 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530673-B2 | Tetrathiafulvalene derivative, and organic film and organic transistor using the same | RICOH COMPANY, LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| EP-2411378-B1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH CO LTD (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-20120035364-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH COMPANY, LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2411378-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | Ricoh Company, Ltd. (JP) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010110351-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH COMPANY, LTD. (JP) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035364-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | TCOF1, F12, F5 | HSD17B10 1467/4885ALDH1A1 2811/4885CYP1A2 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.